Mobile Platform for Optimizing Wellness and Engagement in Recovery

Mobile Platform for Optimizing Wellness and Engagement in Recovery

This pilot study addresses the urgent public health crisis of co-occurring opioid and alcohol use disorders (OUD-AUD), leading causes of mortality in the United States, by testing a scalable digital contingency management (CM) treatment among Medicaid beneficiaries. The study aims to evaluate the feasibility and acceptability of digital CM for OUD-AUD recovery, while also planning for broader implementation.

Inclusion Criteria:

• Participants must be enrolled in the Michigan Medicaid program
• Opioid agonist treatment (OAT): Participants must have initiated OAT with buprenorphine or methadone
• Participants must have an OAT prescription and Alcohol use disorder (AUD) based on self-report measure during screening
• Participants must have regular access to a working smartphone and internet connection.
• Participants must have a reliable mailing address to receive study supplies (e.g., salivary drug tests).

Exclusion Criteria:

• Primary Medicare Coverage: Individuals that are dual-eligible for Medicaid and Medicare and aged 65 or older, due to limited availability of Medicaid claims data for this group
• Individuals that cannot voluntarily provide informed consent themselves for any reason, including legal incompetency
• Individuals with substantial cognitive impairment that would interfere with study participation
• Individuals unable to read or understand English
• Individuals experiencing active suicidality or psychosis.
• Individuals with a planned admission to residential treatment or incarceration during the study period.